Your browser doesn't support javascript.
loading
Association of Cabozantinib Dose Reductions for Toxicity With Clinical Effectiveness in Metastatic Renal Cell Carcinoma (mRCC): Results From the Canadian Kidney Cancer Information System (CKCis).
Graham, Jeffrey; Ghosh, Sunita; Breau, Rodney H; Wood, Lori; Tanguay, Simon; Bosse, Dominick; Lalani, Aly-Khan; Bhindi, Bimal; Heng, Daniel; Finelli, Antonio; Fallah-Rad, Nazanin; Castonguay, Vincent; Basappa, Naveen S; Soulières, Denis; Pouliot, Frédéric; Kollmannsberger, Christian; Bjarnason, Georg A.
Afiliación
  • Graham J; CancerCare Manitoba, Division of Medical Oncology and Hematology, University of Manitoba, Winnipeg, MB, Canada. Electronic address: jgraham9@cancercare.mb.ca.
  • Ghosh S; Department of Medical Oncology, Faculty of Medicine and Dentistry University of Alberta, Edmonton, AB, Canada.
  • Breau RH; Division of Urology, University of Ottawa, Ottawa, ON, Canada.
  • Wood L; Division of Medical Oncology, QEII Health Sciences Center, Halifax, NS, Canada.
  • Tanguay S; Department of Surgery, McGill University, Montreal, QC, Canada.
  • Bosse D; Division of Medical Oncology, University of Ottawa, Ottawa, ON, Canada.
  • Lalani AK; Division of Medical Oncology, McMaster University, Hamilton, ON, Canada.
  • Bhindi B; Division of Urology, University of Calgary, Calgary, AB, Canada.
  • Heng D; Division of Medical Oncology, University of Calgary, Calgary, AB, Canada.
  • Finelli A; Division of Urology, Departments of Surgery and Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada.
  • Fallah-Rad N; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Castonguay V; Centre de recherche du Centre Hospitalier Universitaire de Québec - Université Laval (CRCHUQc-UL), Centre de recherche sur le cancer (CRC) de l'Université Laval, Québec, QC, Canada.
  • Basappa NS; Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, AB, Canada.
  • Soulières D; Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.
  • Pouliot F; Cancer Research Center, Centre Hospitalier Universitaire de Québec - Université Laval, Québec, QC, Canada.
  • Kollmannsberger C; BC Cancer - Vancouver Centre, Vancouver, BC, Canada.
  • Bjarnason GA; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
Clin Genitourin Cancer ; 22(3): 102060, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38521648
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Piridinas / Carcinoma de Células Renales / Inhibidores de Proteínas Quinasas / Neoplasias Renales / Anilidas Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Clin Genitourin Cancer Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2024 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Piridinas / Carcinoma de Células Renales / Inhibidores de Proteínas Quinasas / Neoplasias Renales / Anilidas Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Clin Genitourin Cancer Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2024 Tipo del documento: Article